Overactivation of NF-κβ has been observed in the AD phenotype and its associated symptoms, whereas in vitro research has demonstrated the impact of inflammatory factors on increasing the production of Aβ through the NF-κB signaling pathway (Lingappan, 2018). The gene discussed is NFKB1; the disease is Alzheimer disease.